Homologous recombination knockout blaKPC-2 gene in clinical isolates of Klebsiella pneumonia

Ying ZHANG,Yueru TIAN,Fuqi AI,Hong LIU,Yimin MA,Bei WANG,Xiaofei JIANG

DOI: https://doi.org/10.3969/j.issn.1673-8640.2014.06.006

IF: 1.865

2014-01-01

Laboratory Medicine

Abstract:Objective To establish a method of knocking out drug-resistant genes on plasmid contained by clinical Klebsiella pneumonia drug-resistant isolates.Methods Polymerase chain reaction (PCR)was used to amplify the upstream and downstream fragments of target gene blaKPC-2 of the test isolates and hygromycin resistance gene fragments on plasmid pMQ300,respectively.Gene splicing by overlap extension polymerase chain reaction(SOE-PCR)was used to construct the fusion fragments,and apramycin resistance lambda red plasmid pKOBEG-Apr was used as mediated, homologous recombination knockout blaKPC-2 gene in clinical Klebsiella pneumonia drug-resistant isolates.LB medium containing hygromycin and apramycin was used to screen recombination,and PCR and reverse transcription-polymerase chain reaction (RT-PCR)amplification were used to detect blaKPC-2 gene and hygromycin resistance gene,and drug sensitive test was used to confirm the recombination.Results The blaKPC-2 gene was successfully knocked out in 2 clinical Klebsiella pneumonia drug-resistant isolates with different multilocus sequence typing(MLST).Conclusions Lambda red homologous recombination method can be used to knock out clinical Klebsiella pneumonia drug-resistant isolate plasmid gene reliably.